Tag: NASDAQ:BCLI

Company

Brainstorm Cell Therapeutics, Inc (NASDAQ:BCLI) Is Looking Good Over The Long Term, Dropped Nearly -42.31% Over A Month.

In last trading session, Brainstorm Cell Therapeutics, Inc (NASDAQ:BCLI) saw 0.44 million shares changing hands with its beta currently measuring 0.32. Company’s recent per share

Business

Brainstorm Cell Therapeutics, Inc. (NASDAQ:BCLI) Currently -259.09% Below Its 52-Week High, But There May Be A Surprise Downside

In last trading session, Brainstorm Cell Therapeutics, Inc. (NASDAQ:BCLI) saw 0.54 million shares changing hands with its beta currently measuring 0.33. Company’s recent per share

Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.

Tag: NASDAQ:BCLI

Brainstorm Cell Therapeutics, Inc (NASDAQ:BCLI) Is Looking Good Over The Long Term, Dropped Nearly -42.31% Over A Month.

Brainstorm Cell Therapeutics, Inc. (NASDAQ:BCLI) Currently -259.09% Below Its 52-Week High, But There May Be A Surprise Downside

Quick Links

Categories